Skip to main content
OpenTrials

Clinical trial condition

Gastric Adenocarcinoma

Explore clinical trials studying Gastric Adenocarcinoma. Study availability and eligibility vary by location and protocol.

191 public trials 60 recruiting studies
Refine in advanced search Browse all conditions

Gastric Adenocarcinoma trial results

Recruiting

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

NCT07277413

Conditions
Adenocarcinoma Of Esophagus, Adenocarcinoma of Esophagus, Adenoma, +55 more
Locations
  • Providence Medical Foundation Santa Rosa, California, United States
  • Johns Hopkins Sibley Memorial Hospital Washington D.C., District of Columbia, United States
  • BRCR Global-Coral Springs Coral Springs, Florida, United States
  • Sarah Cannon Research Institute at Florida Cancer Specialists Orlando, Florida, United States
View all 16 locations
View Trial Details
Recruiting

Perioperative HLX10 (Serplulimab) With S-1+Oxaliplatin (SOX) in Locally Advanced and PD-L1-Positive Gastric or Esophagogastric Junction Adenocarcinoma

NCT07699939

Conditions
Adenocarcinoma, Carcinoma, Gastric Adenocarcinoma, +4 more
Locations
  • Chiba Cancer Center Chiba, Japan
  • Kyushu Cancer Center Fukuoka, Japan
  • Gifu University Hospital Gifu, Japan
  • Gunma University Hospital Maebashi, Gunma, Japan
View all 18 locations
View Trial Details
Recruiting

Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of BL-M05D1 in Subjects With Solid Tumors

NCT07021066

Conditions
Adenocarcinoma Of Esophagus, Advanced Pancreatic Ductal Adenocarcinoma, Biliary Tract Cancer, +9 more
Locations
  • Mayo Clinic Cancer Center- Phoenix Phoenix, Arizona, United States
  • HonorHealth Scottsdale, Arizona, United States
  • Valkyrie Clinical Trials Los Angeles, California, United States
  • University of Colorado Health Aurora, Colorado, United States
View all 17 locations
View Trial Details
Recruiting

A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer

NCT05365581

Conditions
Adenocarcinoma, Carcinoma, Gastric Adenocarcinoma, +5 more
Locations
  • University of California Irvine Medical Center Orange, California, United States
  • UCLA Dept of Medicine - Hematology/Oncology, Santa Monica Santa Monica, California, United States
  • Northwestern University Chicago, Illinois, United States
  • University of Kansas Cancer Center Westwood, Kansas, United States
View all 46 locations
View Trial Details
Recruiting

Study of Denikitug (GS-1811) Given Alone or With Nivolumab or Chemotherapy in Adults With Metastatic Gastric, Gastroesophageal Junction (GEJ), and Esophageal Adenocarcinomas

NCT07546812

Conditions
Adenocarcinoma Of Esophagus, Esophageal Adenocarcinoma, Gastric Adenocarcinoma, +2 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Chris O'Brien Lifehouse Camperdown, New South Wales, Australia
  • Royal Brisbane and Women's Hospital Herston, Queensland, Australia
  • Hollywood Private Hospital Nedlands, Western Australia, Australia
View Trial Details
Recruiting

A Study of Pembrolizumab With Trastuzumab and Chemotherapy in People With Esophagogastric Cancer

NCT06123338

Conditions
Digestive System Diseases, Digestive System Neoplasms, Esophageal Cancer, +9 more
Locations
  • Massachusetts General Hospital (Data Collection Only) Boston, Massachusetts, United States
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
View Trial Details

Related conditions